Recommended treatments for alcoholic hepatitis 'fail to keep patients alive'

April 22, 2015 9:03 PM

12 0

LONDON (Reuters) - Two key drugs recommended in international guidelines and used to treat alcoholic hepatitis are failing to increase patients' survival and leave death rates among patients "alarmingly high", researchers said on Wednesday.

In a trial involving more than 1,000 patients, the generic medicines -- prednisolone and pentoxifylline -- were found to make no significant reduction in death rates over 28 days, over 90 days, or even over a year.

Also read: Experimental Ebola Treatment May Be Deployed to Congo

Read more

To category page